BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28104132)

  • 1. Everolimus-Induced Systemic Serositis After Simultaneous Liver and Kidney Transplantation: A Case Report.
    Kim K; Jeong DW; Lee YH; Kim YG; Moon JY; Jeong KH; Lee TW; Ihm CG; Joo SH; Park HC; Lee SH
    Transplant Proc; 2017; 49(1):181-184. PubMed ID: 28104132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-
    Grech P; Mangion J; Vella S
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33472801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial.
    Favi E; Spagnoletti G; Salerno MP; Pedroso JA; Romagnoli J; Citterio F
    Clin Transplant; 2013; 27(4):E359-67. PubMed ID: 23710603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adalimumab-induced lupus serositis.
    Kelly D; O'Connell O; Henry M
    BMJ Case Rep; 2015 Mar; 2015():. PubMed ID: 25739794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine-induced pericarditis, pericardial tamponade, polyserositis, and rash.
    Bhatti MA; Zander J; Reeve E
    J Clin Psychiatry; 2005 Nov; 66(11):1490-1. PubMed ID: 16420089
    [No Abstract]   [Full Text] [Related]  

  • 6. Tacrolimus-Induced Diabetic Ketoacidosis and Effect of Switching to Everolimus: A Case Report.
    Tuğcu M; Kasapoğlu U; Boynueğri B; Can Ö; Gökçe AM; Ruhi Ç; Titiz M
    Transplant Proc; 2015 Jun; 47(5):1528-30. PubMed ID: 26093759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac Tamponade Induced by Tacrolimus Toxicity.
    Doobay R; Gambhir HS
    Am J Ther; 2018; 25(6):e683-e684. PubMed ID: 28708698
    [No Abstract]   [Full Text] [Related]  

  • 8. [Association of idiopathic eosinophilic pleurisy and a severe pericardial effusion].
    Beynel P; Nesme P; Pérol M; Guérin JC
    Rev Mal Respir; 1997 Jun; 14(3):218-20. PubMed ID: 9411599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of everolimus and tacrolimus in kidney transplant patients with intolerance to mycophenolate mofetil/mycophenolic acid.
    Balda S; Inza A; Odriozola N; Zárraga S; García-Erauskin G; Lampreabe I
    Transplant Proc; 2009; 41(6):2095-8. PubMed ID: 19715841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe polyserositis induced by the 13-valent pneumococcal conjugate vaccine: a case report.
    Tawfik P; Gertner E; McEvoy CE
    J Med Case Rep; 2017 May; 11(1):142. PubMed ID: 28526059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine-induced pericarditis.
    Markovic J; Momcilov-Popin T; Mitrovic D; Ivanovic-Kovacevic S; Sekuli S; Stojsic-Milosavljevic A
    Afr J Psychiatry (Johannesbg); 2011 Jul; 14(3):236-8. PubMed ID: 21863209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Everolimus-induced lymphedema in a renal transplant recipient: a case report.
    Ersoy A; Koca N
    Exp Clin Transplant; 2012 Jun; 10(3):296-8. PubMed ID: 22631070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model.
    Jones-Hughes T; Snowsill T; Haasova M; Coelho H; Crathorne L; Cooper C; Mujica-Mota R; Peters J; Varley-Campbell J; Huxley N; Moore J; Allwood M; Lowe J; Hyde C; Hoyle M; Bond M; Anderson R
    Health Technol Assess; 2016 Aug; 20(62):1-594. PubMed ID: 27578428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Everolimus: a guide to its use in liver transplantation.
    Keating GM; Lyseng-Williamson KA
    BioDrugs; 2013 Aug; 27(4):407-11. PubMed ID: 23696253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rejection after simultaneous pancreas-kidney transplantation.
    Arbogast H; Malaise J; Illner WD; Tarabichi A; Dieterle C; Landgraf R; Land W;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii11-7, ii62. PubMed ID: 15814544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion therapy to everolimus in renal transplant recipients: results after one year.
    Giron F; Baez Y; Niño-Murcia A; Rodríguez J; Salcedo S
    Transplant Proc; 2008 Apr; 40(3):711-3. PubMed ID: 18454994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary effects of immunosuppressive drugs after simultaneous pancreas-kidney transplantation.
    Kuypers DR; Malaise J; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii33-9, ii62. PubMed ID: 15814548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of ileal ulcers caused by immunosuppressants in two organ transplant recipients.
    Guo YW; Gu HY; Abassa KK; Lin XY; Wei XQ
    World J Gastroenterol; 2016 Jun; 22(24):5616-22. PubMed ID: 27350740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial.
    Budde K; Becker T; Arns W; Sommerer C; Reinke P; Eisenberger U; Kramer S; Fischer W; Gschaidmeier H; Pietruck F;
    Lancet; 2011 Mar; 377(9768):837-47. PubMed ID: 21334736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indications and management of everolimus after liver transplantation.
    Bilbao I; Sapisochin G; Dopazo C; Lazaro JL; Pou L; Castells L; Caralt M; Blanco L; Gantxegi A; Margarit C; Charco R
    Transplant Proc; 2009; 41(6):2172-6. PubMed ID: 19715864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.